English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch development

MPS-Authors
/persons/resource/persons136451

Borner,  Georg H. H.
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)

2147.full.pdf
(Any fulltext), 2MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Nahorski, M. S., Al-Gazali, L., Hertecant, J., Owen, D. J., Borner, G. H. H., Chen, Y.-C., et al. (2015). A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch development. BRAIN, 138, 2147-2160. doi:10.1093/brain/awv149.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0028-79C9-0
Abstract
Congenital inability to feel pain is rare, but the identification of causative genes is translating into the development of novel analgesics. Nahorski <italic toggle="yes">et al. describe insensitivity to pain caused by mutations affecting the second clathrin heavy chain (CHC22), and reveal a role for CHC22 in pain and touch development.Congenital inability to feel pain is rare, but the identification of causative genes is translating into the development of novel analgesics. Nahorski <italic toggle="yes">et al. describe insensitivity to pain caused by mutations affecting the second clathrin heavy chain (CHC22), and reveal a role for CHC22 in pain and touch development.Congenital inability to feel pain is very rare but the identification of causative genes has yielded significant insights into pain pathways and also novel targets for pain treatment. We report a novel recessive disorder characterized by congenital insensitivity to pain, inability to feel touch, and cognitive delay. Affected individuals harboured a homozygous missense mutation in <italic toggle="yes">CLTCL1 encoding the CHC22 clathrin heavy chain, p.E330K, which we demonstrate to have a functional effect on the protein. We found that CLTCL1 is significantly upregulated in the developing human brain, displaying an expression pattern suggestive of an early neurodevelopmental role. Guided by the disease phenotype, we investigated the role of CHC22 in two human neural crest differentiation systems; human induced pluripotent stem cell-derived nociceptors and TRKB-dependant SH-SY5Y cells. In both there was a significant downregulation of CHC22 upon the onset of neural differentiation. Furthermore, knockdown of CHC22 induced neurite outgrowth in neural precursor cells, which was rescued by stable overexpression of small interfering RNA-resistant CHC22, but not by mutant CHC22. Similarly, overexpression of wild-type, but not mutant, CHC22 blocked neurite outgrowth in cells treated with retinoic acid. These results reveal an essential and non-redundant role for CHC22 in neural crest development and in the genesis of pain and touch sensing neurons.